Q4 2025 Earnings Call March 18, 2026 4:30 PM EDTCompany ParticipantsMaria Sainz - CEO, President & DirectorBrett Hale - ...
Over the past two decades, bioinformatics and systems biology have addressed informational challenges in biomedicine at the molecular and cellular level, leading to the sequencing of the Human Genome ...
Durvalumab with gemcitabine and cisplatin for neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancer TA1138 2 March 2026 2 March 2026 ...